Kathryn Jelle, PA
Medical · Saint Louis Park, MNNPI 1538545686
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,537 of the $2,567 with a category attached, or 98.8%. 4 manufacturers reported payments, led by Johnson & Johnson at 49.2% of the total. Among medical clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 5 payments — averaging $513.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- E.r. Squibb & Sons, L.L.C.$660
- Novartis$630
- Tempus AI, Inc$14
What the payments were for
- Consulting fees$2,53799%
- Food & beverage$141%
- Education$161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $1,263 |
| E.r. Squibb & Sons, L.L.C. | 2 | $660 |
| Novartis | 1 | $630 |
| Tempus AI, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erleada$1,263
How this compares
$2,567 in reported general payments places this provider in the 95th percentile of 202 medical providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 34 | $447,892 |
| RevlimidLenalidomide | 20 | $344,797 |
| Lenalidomide | 23 | $256,653 |
| BrukinsaZanubrutinib | 12 | $183,978 |
| EliquisApixaban | 28 | $27,632 |
| Oxycodone Hcl | 37 | $772 |
| Anastrozole | 13 | $343 |
| Potassium Chloride | 12 | $218 |
| Letrozole | 12 | $192 |
| Acyclovir | 19 | $171 |
| Famotidine | 14 | $137 |
| Prednisone | 16 | $59 |
Paid to pharmacies, not to this prescriber.
Other medical in Saint Louis Park
- Kristina ThissenRogers$178K
- Cynthia KonrathMinnetonka$95K
- Tyler JohnsonWaconia$28K
- Eliza AbrahamWhite Bear Lake$19K
- Tobie MeyerMaple Grove$13K
- Emily BurkmanWhite Bear Lake$6K
- Sarah SeilerMaple Grove$4K
- Kerry GuntliEden Prairie$3K
- Katie PetersonMaple Grove$3K
- Erica DonovanCrosby$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.